None
Quote | Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock (NASDAQ:CYCCP)
Last: | $6.30 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $6.30 |
High: | $0 |
Low: | $0 |
Volume: | 2 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock (NASDAQ:CYCCP)
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesd...
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it has closed its previously announced...
Message Board Posts | Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock (NASDAQ:CYCCP)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CYCCP News Article - Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial | whytestocks | investorshangout | 05/04/2023 5:20:50 PM |
Stock_Tracker: Latest Cyclacel Pharmaceuticals (CYCCP) Headlines Cyclacel Pharmaceuticals to Release | Stock_Tracker | investorshangout | 03/13/2014 11:27:05 AM |
chartguy89: CYCCP Stock Charts Last: +1.11 Thursday, February 27, 2014 at 4:54:23 PM $CYCCP | chartguy89 | investorshangout | 02/27/2014 9:54:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock Company Name:
CYCCP Stock Symbol:
NASDAQ Market:
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the &...
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesd...
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it has closed its previously announced...